Year |
Citation |
Score |
2023 |
Dietrich C, Trub A, Ahn A, Taylor M, Ambani K, Chan KT, Lu KH, Mahendra CA, Blyth C, Coulson R, Ramm S, Watt AC, Matsa SK, Bisi J, Strum J, et al. INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors. Cancer Discovery. PMID 38047585 DOI: 10.1158/2159-8290.CD-23-0954 |
0.358 |
|
2022 |
Zhu H, Chan KT, Huang X, Cerra C, Blake S, Trigos AS, Anderson D, Creek DJ, De Souza DP, Wang X, Fu C, Jana M, Sanij E, Pearson RB, Kang J. Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation. Elife. 11. PMID 35758651 DOI: 10.7554/eLife.71929 |
0.311 |
|
2020 |
Kusnadi EP, Trigos AS, Cullinane C, Goode DL, Larsson O, Devlin JR, Chan KT, De Souza DP, McConville MJ, McArthur GA, Thomas G, Sanij E, Poortinga G, Hannan RD, Hannan KM, et al. Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis. The Embo Journal. e105111. PMID 32945574 DOI: 10.15252/Embj.2020105111 |
0.346 |
|
2020 |
Zhu H, Blake S, Kusuma FK, Pearson RB, Kang J, Chan KT. Oncogene-Induced Senescence: from Biology to Therapy. Mechanisms of Ageing and Development. 111229. PMID 32171687 DOI: 10.1016/J.Mad.2020.111229 |
0.416 |
|
2019 |
AbuHammad S, Cullinane C, Martin C, Bacolas Z, Ward T, Chen H, Slater A, Ardley K, Kirby L, Chan KT, Brajanovski N, Smith LK, Rao AD, Lelliott EJ, Kleinschmidt M, et al. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 31439820 DOI: 10.1073/Pnas.1901323116 |
0.424 |
|
2019 |
Chan KT, Blake S, Zhu H, Kang J, Trigos AS, Madhamshettiwar PB, Diesch J, Paavolainen L, Horvath P, Hannan RD, George AJ, Sanij E, Hannan KM, Simpson KJ, Pearson RB. A functional genetic screen defines the AKT-induced senescence signaling network. Cell Death and Differentiation. PMID 31285545 DOI: 10.1038/S41418-019-0384-8 |
0.417 |
|
2018 |
Zhu H, Blake S, Chan KT, Pearson RB, Kang J. Cystathionine -Synthase in Physiology and Cancer. Biomed Research International. 2018: 3205125. PMID 30050925 DOI: 10.1155/2018/3205125 |
0.368 |
|
2017 |
Yan S, Frank D, Son J, Hannan KM, Hannan RD, Chan KT, Pearson RB, Sanij E. The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer. International Journal of Molecular Sciences. 18. PMID 28117679 DOI: 10.3390/Ijms18010210 |
0.346 |
|
2017 |
Yan S, Chan KT, Simpson KJ, Sanij E, Sheppard KE, Hannan KM, Hannan RD, Pearson RB. Abstract A24: A genome-wide RNAi screen identifies synthetic lethality of CX-5461 with homologous recombination repair deficiency in ovarian cancer Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-A24 |
0.411 |
|
2016 |
Chan KT, Paavolainen L, Hannan KM, George AJ, Hannan RD, Simpson KJ, Horvath P, Pearson RB. Combining High-Content Imaging and Phenotypic Classification Analysis of Senescence-Associated Beta-Galactosidase Staining to Identify Regulators of Oncogene-Induced Senescence. Assay and Drug Development Technologies. 14: 416-428. PMID 27552145 DOI: 10.1089/Adt.2016.739 |
0.441 |
|
2016 |
Quin J, Chan KT, Devlin JR, Cameron DP, Diesch J, Cullinane C, Ahern J, Khot A, Hein N, George AJ, Hannan KM, Poortinga G, Sheppard KE, Khanna KK, Johnstone RW, et al. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling. Oncotarget. PMID 27391441 DOI: 10.18632/Oncotarget.10452 |
0.36 |
|
2015 |
Creed SJ, Le CP, Hassan M, Pon CK, Albold S, Chan KT, Berginski ME, Huang Z, Bear JE, Lane JR, Halls ML, Ferrari D, Nowell CJ, Sloan EK. β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Research : Bcr. 17: 145. PMID 26607426 DOI: 10.1186/S13058-015-0655-3 |
0.453 |
|
2015 |
Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, et al. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2167-76. PMID 25934889 DOI: 10.1158/1078-0432.Ccr-14-1826 |
0.334 |
|
2014 |
Chan KT, Asokan SB, King SJ, Bo T, Dubose ES, Liu W, Berginski ME, Simon JM, Davis IJ, Gomez SM, Sharpless NE, Bear JE. LKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues. The Journal of Cell Biology. 207: 299-315. PMID 25349262 DOI: 10.1083/Jcb.201404067 |
0.452 |
|
2013 |
Chan KT, Asokan SB, Bo T, Berginski ME, Liu W, Cochran SD, Sharpless NE, Bear JE. Abstract C14: Loss of haptotaxis facilitates invasion in LKB1-deficient melanoma Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C14 |
0.41 |
|
2013 |
Debebe Z, Porter M, Hull-Ryde EE, Rasmussen N, Sendor A, Norris-Drouin J, Chan K, Bear JE, Janzen WP, Rathmell K. Abstract B206: Ror2 as a therapeutic target in renal cell carcinoma and other invasive cancers. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B206 |
0.48 |
|
2012 |
Liu W, Monahan KB, Pfefferle AD, Shimamura T, Sorrentino J, Chan KT, Roadcap DW, Ollila DW, Thomas NE, Castrillon DH, Miller CR, Perou CM, Wong KK, Bear JE, Sharpless NE. LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma. Cancer Cell. 21: 751-64. PMID 22698401 DOI: 10.1016/J.Ccr.2012.03.048 |
0.321 |
|
2012 |
Chan KT, Roadcap DW, Holoweckyj N, Bear JE. Coronin 1C harbours a second actin-binding site that confers co-operative binding to F-actin. The Biochemical Journal. 444: 89-96. PMID 22364218 DOI: 10.1042/Bj20120209 |
0.31 |
|
2011 |
Chan KT, Creed SJ, Bear JE. Unraveling the enigma: progress towards understanding the coronin family of actin regulators. Trends in Cell Biology. 21: 481-8. PMID 21632254 DOI: 10.1016/J.Tcb.2011.04.004 |
0.408 |
|
2010 |
Chan KT, Bennin DA, Huttenlocher A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). The Journal of Biological Chemistry. 285: 11418-26. PMID 20150423 DOI: 10.1074/Jbc.M109.090746 |
0.68 |
|
2010 |
Chan KT, Bennin DA, Huttenlocher A. Regulation of adhesion dynamics by calpain-mediated proteolysis of FAK F1000research. 1. DOI: 10.7490/F1000Research.41.1 |
0.635 |
|
2009 |
Chan KT, Cortesio CL, Huttenlocher A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. The Journal of Cell Biology. 185: 357-70. PMID 19364917 DOI: 10.1083/Jcb.200809110 |
0.771 |
|
2008 |
Cortesio CL, Chan KT, Perrin BJ, Burton NO, Zhang S, Zhang ZY, Huttenlocher A. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. The Journal of Cell Biology. 180: 957-71. PMID 18332219 DOI: 10.1083/Jcb.200708048 |
0.69 |
|
2008 |
Cortesio CL, Chan KT, Huttenlocher A. Adhesion Dynamics in Motile Cells Cell Junctions: Adhesion, Development, and Disease. 71-88. DOI: 10.1002/9783527622092.ch4 |
0.736 |
|
2007 |
Lokuta MA, Senetar MA, Bennin DA, Nuzzi PA, Chan KT, Ott VL, Huttenlocher A. Type Igamma PIP kinase is a novel uropod component that regulates rear retraction during neutrophil chemotaxis. Molecular Biology of the Cell. 18: 5069-80. PMID 17928408 DOI: 10.1091/Mbc.E07-05-0428 |
0.699 |
|
2007 |
Chan KT, Cortesio CL, Huttenlocher A. Integrins in cell migration. Methods in Enzymology. 426: 47-67. PMID 17697879 DOI: 10.1016/S0076-6879(07)26003-3 |
0.755 |
|
Show low-probability matches. |